ClinConnect ClinConnect Logo
Search / Trial NCT07016880

Anxiety, Physiological Parameters, Patient Satisfaction and VR in Gynecological Oncology Surgery

Launched by HACETTEPE UNIVERSITY · Jun 11, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Gynecological Surgery Gynecological Oncology Preoperative Anxiety Preoperative Anxiety Management Virtual Reality

ClinConnect Summary

This clinical trial is studying how virtual reality (VR) can help reduce anxiety in women who are about to undergo surgery for gynecological cancer. Many women feel anxious before surgery, which can affect their heart rate, blood pressure, and overall experience. The trial aims to see if using VR, which offers a calming and immersive experience, can lower anxiety levels and improve satisfaction with the preoperative process. Participants will be randomly assigned to either use VR before surgery or receive standard care without VR.

To be eligible for this trial, women must be at least 18 years old, have a confirmed diagnosis of gynecological cancer, and this must be their first surgery related to this diagnosis. They should also be able to understand and communicate in Turkish. If you join this study, you can expect to have your anxiety and physical responses measured before and after the VR experience or standard care, along with providing feedback on how satisfied you feel with the pre-surgery process. This research could help improve care for women facing gynecological cancer surgeries by finding effective ways to manage preoperative anxiety without medication.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • The participant must have a confirmed diagnosis of gynecological cancer.
  • The participant must be aware of their gynecological cancer diagnosis.
  • Participants must be 18 years of age or older.
  • Verbal and written informed consent to participate in the study must be obtained.
  • The participant must be able to communicate verbally and in writing in Turkish.
  • No communication impairments (e.g., visual, auditory, or cognitive) should be present.
  • This must be the participant's first surgical intervention related to gynecological oncology.
  • Eastern Cooperative Oncology Group (ECOG) Performance Status must not exceed 2.
  • The planned surgical procedure must be a laparotomy.
  • Exclusion Criteria:
  • History of recurrent gynecological cancer.
  • Presence of vision problems that prevent the use of VR goggles, including participants who wear glasses or have uncorrected vision impairment.
  • Presence of conditions such as migraines, vertigo, active nausea, vomiting, or frequent headaches.
  • Sensitivity to motion sickness.
  • Diagnosis of a psychiatric condition, whether under pharmacological or non-pharmacological treatment.
  • Withdrawal of consent during the study.
  • Removal of the virtual reality headset during the intervention.
  • Development of any medical complications during the intervention period.

About Hacettepe University

Hacettepe University is a leading research institution in Turkey, renowned for its commitment to advancing medical science and healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, the university supports a wide range of clinical trials aimed at improving patient outcomes and developing new therapeutic approaches. Hacettepe University is dedicated to maintaining the highest ethical standards and regulatory compliance in its research endeavors, fostering an environment that promotes scientific excellence and contributes to the global body of medical knowledge.

Locations

Ankara, , Turkey

Patients applied

0 patients applied

Trial Officials

Fatma Uslu Sahan, Assoc Prof

Principal Investigator

Hacettepe University Faculty of Nursing

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported